Tianjin Zhong Xin Pharma posts 6% rise in FY20 earnings to $135.8 mil | The Edge Singapore 2021-03-30T10:04:23-04:00March 30th, 2021| share this article! Read More share this article! Related Posts Amazon’s AWS commits extra S$12 billion to boost Singapore cloud infrastructure May 7th, 2024 New Thai finance chief wants monetary, fiscal policies aligned May 7th, 2024 Scoot begins flights with Embraer E190-E2 jet May 7th, 2024 Swiss-Asia Financial Services fined S$2.5 million for money-laundering rule breaches May 7th, 2024